Advanced Biomed (ADVB) Cash from Financing Activities (2024 - 2026)
Advanced Biomed (ADVB) posted Cash from Financing Activities of -$373480.0 for Q1 2026, down 218.39% sequentially from $315477.0 in Q4 2025, and down 106.0% YoY from $6.2 million in Q1 2025.
Advanced Biomed (ADVB) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Advanced Biomed (ADVB) has 3 years of Cash from Financing Activities data on file, last reported at -$373480.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 106.0% year-over-year to -$373480.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$376007.0 (down 105.35% YoY) and the FY2025 annual result came in at $5.9 million, up 217.88% from the prior year.
- Cash from Financing Activities eased to -$373480.0 in Q1 2026 per ADVB's latest filing, from $315477.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $6.2 million in Q1 2025, with the low at -$765466.0 in Q2 2025.
- Average Cash from Financing Activities over 3 years is $801055.0, with a median of $323536.0 recorded in 2024.
- The widest YoY moves for Cash from Financing Activities: up 1007.96% in 2025, down 336.59% in 2025.
- Advanced Biomed's Cash from Financing Activities stood at $78327.0 in 2024, then surged by 302.77% to $315477.0 in 2025, then plunged by 218.39% to -$373480.0 in 2026.
- Business Quant data shows ADVB's Cash from Financing Activities at -$373480.0 in Q1 2026, $315477.0 in Q4 2025, and $447462.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Advanced Biomed | 6.22 Mn | 6.22 Mn | - | -373,480.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -373,480.00 |
| Mar 31, 2026 | -373,480.00 |
| Dec 31, 2025 | 315,477.00 |
| Dec 31, 2025 | 315,477.00 |
| Sep 30, 2025 | 447,462.00 |
| Sep 30, 2025 | 447,462.00 |
| Jun 30, 2025 | -765,466.00 |
| Jun 30, 2025 | -765,466.00 |
| Mar 31, 2025 | 6.23 Mn |
| Mar 31, 2025 | 6.23 Mn |
| Dec 31, 2024 | 78,327.00 |
| Dec 31, 2024 | 78,327.00 |
| Sep 30, 2024 | 392,525.00 |
| Sep 30, 2024 | 392,525.00 |
| Jun 30, 2024 | 323,536.00 |
| Jun 30, 2024 | 323,536.00 |
| Mar 31, 2024 | 562,199.00 |
| Mar 31, 2024 | 562,199.00 |